Jacob Sands, MD, oncology medical director, Worldwide Affected person Middle, Dana-Farber Most cancers Institute; assistant professor, Harvard Medical Faculty, discusses the evolution of...
AstraZeneca acknowledged: “The Meals and Drug Administration’s Oncologic Medicine Advisory Committee – ODAC – acknowledged that AstraZeneca’s Imfinzi met the first endpoint of...
